Olympus is facing more pushback over endoscopes tied to drug-resistant superbug outbreaks at U.S. hospitals, as new reports show the company asked the FDA to soften its guidelines on cleaning procedures for the products.
The FDA has cleared a neck-worn device to reduce the symptoms of laryngopharyngeal reflux. That condition occurs once gastroesophageal reflux disease (GERD) is so severe that stomach acid travels up the esophagus and into the throat.
Houston is synonymous with oil and gas, but the inaugural class of the Texas Medical Center's TMCx accelerator attests to the city's med tech ambitions. Essentially, all of the 22 startups are in the device or health IT arena. There isn't a pure-play drug developer in the mix.
Cancer diagnostics has long been defined by the aim of providing "personalized" and "precision" medicine to patients. But now the buzzword of the moment seems to be trending more toward "universal"--as the industry strives for an all-encompassing test that will mete out the best possible individual treatment protocols based on genomic data.
Researchers at England's University of Hertfordshire have designed a robotic glove to help victims of stroke rehabilitate.
Sequenom has long depended on its noninvasive prenatal diagnostic test to drive growth and fuel expansion. But now, the company unveiled new results which show that its MaterniT21 test can detect signs of cancer in pregnant women, a potential game-changer as Sequenom looks to expand its market reach.
RayVio is promising a high-performance, low-cost ultraviolet LED system that can be used to aid in disinfection across industrial, commercial and consumer sectors. To support this ambition, the startup has raised a $9.3 million Series B financing.
It's one of those ideas that sounds wacky and way out there, but researchers at the University of California, San Diego, have apparently found a way to draw a blood glucose sensor onto a patient's skin using regular ballpoint pen.
Veniti started its 200-person trial of the Vici Venous Stent System on Dec. 1. Now it's got more than $17 million to complete that trial that is targeting a U.S. approval to treat venous disease.
In typical Apple style, CEO Tim Cook announced the debut of its open-source platform for creating mobile medical apps while standing in front of a black background at a glitzy event in San Francisco. But the news contained substance too, at least from a med tech perspective.
A new study suggests that integrating a biomarker based on data from an electroencephalogram can offer pediatricians a more accurate way to diagnose attention deficit hyperactivity disorder (ADHD) in children, thereby helping to eliminate unnecessary drug therapy.
AliveCor's latest upgrade to its AliveECG app for detecting a sign of stroke known as atrial fibrillation includes a detector to inform patients when their reading is normal and an interference detector to ensure that all results are high quality and readable by physicians.
The U.S. Food and Drug Administration has approved the ResQCPR System to perform cardiopulmonary resuscitation (CPR) on cardiac arrests patients. The CPR system is from startup Advanced Circulatory Systems, which was acquired for an undisclosed amount by Zoll Medical in January.
The medical device tax is costing the med tech industry money--and so is lobbying to get rid of it.
The share price of China's Mindray Medical rose 16% last week on the New York Stock Exchange amid rumors that it will be taken over by private equity firms, including the country's state-owned investment company.
Startup CDx has raised its first institutional round of $6.9 million to market its portable chemical analyzer, MyDx. The device is intended to provide consumers with data about the chemicals in practically anything they are eating, drinking and breathing. So far, 105 investors are participating in the latest financing, which the company hopes will top out at $8 million.
As the drug-resistant "superbug" outbreak tied to endoscopes rages on, patient advocates and healthcare groups are calling for increased transparency about the devices from regulators and providers.
The FDA just approved a first-of-its-kind blood purifier to treat a complication of kidney failure under its pathway for medical devices that treat rare conditions.
CRO giant Icon continues to expand its portfolio of offerings with the launch of a new medical device and diagnostics research group.
Siemens will officially spin off its healthcare business into a separate company as of May 1, according to a report by Reuters. That's earlier than the second half of 2015 timing the company had previously cited.